We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The recent flood of negative news about drug safety concerns has hurt the image of drugmakers in the eyes of both consumers and physicians, but doctors also say media attention has blown out of proportion, a new poll finds.
The nonpartisan Congressional Budget Office (CBO) has boosted its cost estimate for the Medicare prescription drug benefit, in part because the law’s final rules allow drug plan sponsors to design more generous Rx formularies than had been expected.
Before safety concerns over Cox-2 inhibitors and antidepressant use in children made front-page headlines, the pharmaceutical industry had to deal with revelations that widely used hormone replacement therapies (HRTs) posed significant health risks — a finding that is now being questioned by an industry analyst.
Tremendous advances in the biopharmaceutical sciences, including in the field of genomics, have given pharmaceutical firms vast amounts of new information on which to develop drugs — a key development that will fundamentally change the way drugmakers operate, industry experts say.
A proposal to grant the HHS secretary the authority to negotiate Medicare drug prices with manufacturers was defeated in the Senate late March 17 by a single vote.
The Justice Department is investigating GlaxoSmithKline’s (GSK) use of nominal pricing arrangements to determine whether the pricing strategy violates Medicaid price-reporting rules.
The American public is growing increasingly doubtful of the FDA’s ability to ensure the safety of prescription drugs, according to a new national poll.
Nearly two-thirds of Americans want the government to do more to regulate prescription drug prices, according to a new healthcare poll that finds most adults still have a low opinion of the drug industry.
The growth in prescription drug spending will continue its slowdown over the next decade despite an expected boost in drug usage when the Medicare Rx benefit starts in 2006, according to a new Centers for Medicare & Medicaid Services (CMS) study.